A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Exploring the Mechanism of Guben Pingchuan Granule in the Treatment of Bronchial Asthma

75 views

⸱

DOI:

10.3791/70564

⸱

July 14th, 2026

In This Article

Summary

This protocol investigates the mechanism of action of Guben Pingchuan granules in bronchial asthma using network pharmacology, molecular docking, and in vivo. validation.

Abstract

This study investigates the mechanism of action of Guben Pingchuan granules in the treatment of bronchial asthma using network pharmacology, molecular docking, and experimental validation. Active ingredients and corresponding targets were identified using TCMSP, HERB, and SymMap databases. Bronchial asthma-related targets were collected from GeneCards, OMIM, TTD, DrugBank, and PharmGKB. Overlapping targets were identified, and component–target and protein–protein interaction (PPI) networks were constructed. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were performed with false discovery rate (FDR) correction. Molecular docking was conducted to evaluate binding affinity, followed by in vivo validation. A total of 121 active components and 234 drug-related targets were identified, yielding 155 overlapping targets. Core targets included TP53, AKT1, TNF, and IL6. KEGG analysis demonstrated significant enrichment of the PI3K–Akt signaling pathway, which was selected for experimental validation. Molecular docking revealed a strong binding affinity between core components and AKT1. In ovalbumin-induced asthmatic rats, Guben Pingchuan granule reduced serum IL-4 and IL-10 levels, increased FoxP3 expression in lung tissue, and upregulated PI3K and AKT mRNA levels. These findings indicate that Guben Pingchuan granule alleviates bronchial asthma by modulating the PI3K–Akt. signaling pathway, regulating inflammatory cytokines, and enhancing regulatory T cell function.

Introduction

Bronchial asthma is a heterogeneous chronic respiratory disease characterized by airway inflammation, airway hyperresponsiveness, mucus hypersecretion, and airway remodeling1. Its pathogenesis involves complex interactions among immune cell activation, inflammatory mediators, and multiple signaling pathways. Clinically, asthma presents with recurrent wheezing, dyspnea, chest tightness, and cough. Airway inflammation is a central mechanism underlying disease onset and progression, characterized by increased secretion of pro-inflammatory cytokines such as IL-6, IL-4, IL-17, and TNF-α., infiltration of inflammatory cells inc....

Access restricted. Please log in or start a trial to view this content.

Protocol

All animal procedures were approved by the Animal Ethics Committee of Liaoning University of Traditional Chinese Medicine (Approval No.: 21000042023058) and performed in accordance with institutional guidelines. The research tools used in this protocol are listed in the Table of Materials.

1. Databases and software

  1. Access the following databases and software: TCMSP, HERB, SymMap, PubChem, STRING, GeneCards, OMIM, TTD, DrugBank, PharmGKB, DAVID, UniProt, and Cytoscape (version 3.9.1).

2. Acquisition of component targets

  1. Retrieve chem....

Access restricted. Please log in or start a trial to view this content.

Results

Screening of active ingredients
A total of 121 active components were identified from the TCMSP database after filtering for target activity. These included 23 components from Ephedra Herb, 7 from Psoralea, 19 from Apricot seed, 8 from Pseudostellaria root, 16 from Perilla fruit, 18 from Loquat leaf, 7 from Lilium, and 23 from Epimedium. (Table 2). Sixteen common components were identified, including luteolin, quercetin, β-sitosterol, kaem.......

Access restricted. Please log in or start a trial to view this content.

Discussion

Bronchial asthma is a common disease in the respiratory department16. It is an obstructive airway disorder caused by allergens and airway hyperresponsiveness17. It has a high clinical incidence, is prone to recurrence, and is difficult to cure, significantly affecting patients' health and quality of life. The 2025 Global Initiative for Asthma (GINA) reports that inhaled glucocorticoid therapy is effective for asthma18; however, long-term use may .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare no conflict of interest.

Acknowledgements

The authors thank all colleagues for their assistance. This work was supported by the Liaoning Provincial Department of Education General Project, “Research on the Mechanism of Guben Pingchuan Granules on Airway Inflammation and Immune Regulation in Bronchial Asthma from the Perspectives of Gene Expression Profiling and Metabolomics”; the “Xingliao Talent Program” Medical Expert Project; and the Outstanding Talent in Traditional Chinese Medicine (Clinical) of Liaoning Province.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
 qPCR KitNovogeneNQ-001, 2×1mLDetection of relative mRNA expression of target genes
aluminum hydroxide Al(OH)3Shanghai Yubo Biotechnology Co., LTDYB-AL001, 500gImmunological adjuvant to enhance antigen immune response
BCA protein Concentration Test KitFode Biotechnology Co., LTDFD2001, 100 pieces per boxTotal protein quantification to standardize sample loading
Chemiluminescence imaging system Tanon5200MultiWB band imaging, gel and blot image collection and analysis
Color Pre-stained Protein Marker Biolaibo Technology Co., LTDBL005, 10-180kDa, 500μLProtein molecular weight reference for electrophoresis experiments
Enhanced RNA Extraction KitWhole Golden BranchET111-01v2, 50 pieces per boxExtraction and purification of total RNA from tissues and cells
Enzyme-linked immunosorbent assay readerU.S. Biotek CompanyEpoch/BioTekQuantitative detection of cytokines and protein contents in samples
FOXP3 primary antibodyBiyun Tian Biotechnology Co., LTDAG5002, 50ul/pieceTargeted binding to FOXP3 protein for immunoassay
Gel Rapid Preparation Kit Shanghai YameiPG212, 30 setsRapid preparation of separating gel and stacking gel for electrophoresis
masson Staining Kit Solabao Biotechnology Co., LTDG1340, 100 tabletsSpecific staining for tissue collagen fibers and fibrosis observation
OVABeijing Boaotoda Technology Co., LTD.OVA-10g, ≥98%Classical allergen for establishing allergic animal models
primary Antibody Dilution solution Biyun Tian Biotechnology Co., LTDP0256-100mlDilute primary antibody, maintain activity and reduce non-specific binding
Rat IL-10ELISA KitAndy BioE-30649, 96TQuantitative detection of rat IL-10 anti-inflammatory factor
Rat IL-4ELISA KitAndy BioE-30623, 96TQuantitative detection of rat Th2 inflammatory factor IL-4
Reverse Transcription Kit Baori Medical Technology Co., LTD E047-01AReverse transcription of RNA into cDNA for subsequent gene analysis
Saturated Oil Red O KitSolabao Biotechnology Co., LTDG1261, 50mL×2 bottleSpecific staining and detection of tissue lipid droplets
Shangyang Anti-Rabbit Secondary AntibodyProteintech Biological Co., LTDSA00001-2, 1mLBind to rabbit primary antibody for WB color reaction
TBST BufferWuhan Sewell Biotechnology Co., LTDG2150, 1L / bottleBuffer for membrane washing and antibody dilution in Western blot
Transfer Electrophoresis SystemShanghai Jingcanshi Precision Machinery Co., Ltd.PowerPac BasicUsed for protein electrophoresis and Western blot membrane transfer
Ultra-low temperature refrigeratorZhongke MeilingMDF-382Low-temperature cryopreservation of reagents, protein samples and tissues
Vertical electrophoresis tankBIO-RADJY-ZY5Vertical electrophoretic separation of protein and nucleic acid samples

Reprints and Permissions

Tags

Network PharmacologyMolecular DockingExperimental ValidationPI3K-Akt PathwayProtein Interaction NetworkInflammatory CytokinesRegulatory T CellsKEGG Enrichment